Malaysiakini

Pfizer says South African variant could significantly reduce vaccine protection

Reuters

Published

A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.

The study found the vaccine was still able to neutralise the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said...

All Access Plan
starting from

~RM12

per month
Subscribe Now
You can cancel anytime.
Get unlimited access to our articles on web and apps
Add comments to our articles
Bookmark articles to read later
We accept
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In